←Back to structures
KC960489.1__AHB79300.1__MaF1660_ph0106__00105
Bact-VirKC960489.1__AHB79300.1__MaF1660_ph0106__00105
Identity
- Accession:
- KC960489 ↗
- Kingdom:
- phage
Quality
86.1
mean pLDDT
Cluster
View cluster (2 members)3D Structure
Domains
high = three domain segmentations agree, medium = two domain segmentations agree. Numbered high-first then medium, N→C within each tier.
D1
high
residues 60-180
Domain cluster:
representative
CATH (50)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3ub1A01 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.83 | 73.0 | 7.01e-01 | 92.6% | 90.4% |
| 3soyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 63.0 | 6.02e-01 | 95.0% | 93.7% |
| 3b8lA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 63.0 | 5.96e-01 | 95.0% | 91.5% |
| 3mg1B02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 60.0 | 6.01e-01 | 90.1% | 92.0% |
| 4l8oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 65.0 | 5.85e-01 | 100.0% | 82.3% |
| 4x2oA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 61.0 | 5.37e-01 | 94.2% | 90.5% |
| 7c5yA02 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 59.0 | 5.47e-01 | 90.1% | 100.0% |
| 3ebyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 62.0 | 5.72e-01 | 95.9% | 92.2% |
| 3ef8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 62.0 | 5.83e-01 | 97.5% | 88.5% |
| 3a76A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 63.0 | 6.05e-01 | 98.3% | 96.4% |
| 2b1xB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 63.0 | 5.62e-01 | 97.5% | 92.2% |
| 2i9wA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 57.0 | 5.02e-01 | 86.8% | 60.8% |
| 1tp6A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 58.0 | 5.80e-01 | 90.1% | 98.4% |
| 3e99A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 60.0 | 5.66e-01 | 95.0% | 92.6% |
| 3fsdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 58.0 | 5.90e-01 | 91.7% | 98.3% |
| 1vqqA01 | 3.10.450.100 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › NTF2-like; domain 1 | 0.68 | 57.0 | 5.95e-01 | 88.4% | 100.0% |
| 3bb9B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 57.0 | 5.73e-01 | 91.7% | 98.4% |
| 5bkaE01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 59.0 | 5.78e-01 | 95.0% | 100.0% |
| 3hzpA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 58.0 | 5.75e-01 | 92.6% | 94.5% |
| 3rgaA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 60.0 | 5.81e-01 | 94.2% | 91.0% |
| 5ig0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 58.0 | 5.71e-01 | 93.4% | 98.5% |
| 3b7cA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 57.0 | 5.81e-01 | 91.7% | 100.0% |
| 3robA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 60.0 | 5.88e-01 | 98.3% | 98.5% |
| 3d9rB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 61.0 | 5.96e-01 | 100.0% | 99.2% |
| 4o3vA00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.67 | 61.0 | 5.82e-01 | 98.3% | 97.1% |
| 5cxoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.67 | 58.0 | 5.66e-01 | 94.2% | 89.6% |
| 2gtlO02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.66 | 46.0 | 4.13e-01 | 94.2% | 52.8% |
| 1s5aB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.64 | 57.0 | 5.40e-01 | 98.3% | 91.6% |
| 4jf8A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.64 | 56.0 | 5.32e-01 | 95.9% | 94.4% |
| 2r4iA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 55.0 | 5.49e-01 | 95.9% | 97.6% |
| 4h3uA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 54.0 | 5.30e-01 | 93.4% | 90.0% |
| 3ke7B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 56.0 | 5.45e-01 | 98.3% | 95.5% |
| 3eyrA00 | 3.15.10.40 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Uncharacterised protein PF07273 family, DUF1439 | 0.62 | 48.0 | 4.29e-01 | 98.3% | 58.0% |
| 3dm8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 52.0 | 5.10e-01 | 92.6% | 91.9% |
| 2rsxA00 | 3.10.450.420 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 54.0 | 4.97e-01 | 98.3% | 100.0% |
| 1qwdB00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.60 | 38.0 | 3.48e-01 | 89.3% | 46.4% |
| 3hk4A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.60 | 51.0 | 5.16e-01 | 92.6% | 98.3% |
| 3kspA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.59 | 52.0 | 5.11e-01 | 98.3% | 96.9% |
| 1bp1A01 | 3.15.10.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Bactericidal permeability-increasing protein; domain 1 | 0.58 | 53.0 | 4.62e-01 | 100.0% | 73.9% |
| 3grdA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.58 | 49.0 | 4.80e-01 | 92.6% | 91.7% |
| 1qftB00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.57 | 41.0 | 3.69e-01 | 91.7% | 52.7% |
| 3ec9A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.57 | 49.0 | 4.83e-01 | 95.0% | 93.0% |
| 3ff2A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.57 | 47.0 | 4.83e-01 | 91.7% | 98.3% |
| 3fgyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.56 | 50.0 | 4.84e-01 | 97.5% | 91.9% |
| 2rckA01 | 3.15.10.30 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › TULIP domain | 0.56 | 49.0 | 4.11e-01 | 99.2% | 68.3% |
| 2gtlN02 | 2.40.128.620 | Mainly Beta › Beta Barrel › Lipocalin › | 0.55 | 45.0 | 4.08e-01 | 92.6% | 64.1% |
| 1ewfA02 | 3.15.20.10 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 2 › Bactericidal permeability-increasing protein; domain 2 | 0.53 | 47.0 | 3.66e-01 | 100.0% | 75.4% |
| 1so7A00 | 2.120.10.10 | Mainly Beta › 6 Propeller › Neuraminidase › | 0.52 | 47.0 | 3.38e-01 | 100.0% | 49.0% |
| 3bf2A00 | 3.30.160.150 | Alpha Beta › 2-Layer Sandwich › Double Stranded RNA Binding Domain › Lipoprotein like domain | 0.51 | 39.0 | 3.94e-01 | 83.5% | 86.4% |
| 1yliB00 | 3.10.129.10 | Alpha Beta › Roll › Thiol Ester Dehydrase; Chain A › Hotdog Thioesterase | 0.50 | 38.0 | 3.61e-01 | 80.2% | 77.0% |
ECOD (87)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3288890 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.81 | 75.0 | 7.30e-01 | 97.5% | 100.0% |
| 3959534 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.79 | 73.0 | 7.04e-01 | 99.2% | 97.8% |
| 3290399 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.78 | 72.0 | 6.85e-01 | 100.0% | 95.7% |
| 3962486 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.78 | 72.0 | 6.58e-01 | 100.0% | 86.4% |
| 3278986 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.77 | 72.0 | 6.58e-01 | 100.0% | 86.5% |
| 3588474 | 243.1.1.17 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TpcC | 0.77 | 65.0 | 6.62e-01 | 90.9% | 98.3% |
| 3962739 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.77 | 71.0 | 6.55e-01 | 99.2% | 88.0% |
| 4011472 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.76 | 70.0 | 6.09e-01 | 100.0% | 95.6% |
| 4189419 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.75 | 69.0 | 6.39e-01 | 99.2% | 88.0% |
| 3971296 | 243.1.1.5 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Tim44 | 0.75 | 67.0 | 6.58e-01 | 96.7% | 96.1% |
| 3808862 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.75 | 68.0 | 6.55e-01 | 100.0% | 95.7% |
| 3958465 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.75 | 67.0 | 6.25e-01 | 97.5% | 86.7% |
| 3963115 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.75 | 68.0 | 6.39e-01 | 99.2% | 91.0% |
| 3974899 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.74 | 69.0 | 6.45e-01 | 100.0% | 95.2% |
| 6405 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.74 | 66.0 | 6.41e-01 | 95.0% | 96.2% |
| 3952458 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 68.0 | 6.66e-01 | 100.0% | 98.5% |
| 3970236 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.74 | 66.0 | 6.29e-01 | 95.9% | 93.5% |
| 5002369 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 63.0 | 6.48e-01 | 90.9% | 98.3% |
| 4021528 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 65.0 | 6.12e-01 | 96.7% | 96.5% |
| 3732871 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.73 | 66.0 | 5.84e-01 | 100.0% | 87.1% |
| 3957821 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.73 | 64.0 | 6.32e-01 | 95.9% | 99.2% |
| 3970009 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 65.0 | 5.81e-01 | 97.5% | 88.8% |
| 3588483 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 66.0 | 6.36e-01 | 97.5% | 96.3% |
| 3828738 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.72 | 62.0 | 5.75e-01 | 93.4% | 83.9% |
| 3290450 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.72 | 66.0 | 6.24e-01 | 100.0% | 95.8% |
| 3826602 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.72 | 61.0 | 5.85e-01 | 91.7% | 87.9% |
| 4025319 | 881.1.1.2 ↗ | a+b three layers › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1p/PsbP-like › Mog1 | 0.71 | 48.0 | 4.31e-01 | 93.4% | 49.4% |
| 3286818 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 58.0 | 5.72e-01 | 86.0% | 100.0% |
| 4927707 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.71 | 62.0 | 5.96e-01 | 95.9% | 98.6% |
| 5022156 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.71 | 63.0 | 6.07e-01 | 97.5% | 94.9% |
| 4608992 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.71 | 60.0 | 5.45e-01 | 90.9% | 91.8% |
| 3731191 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.71 | 63.0 | 5.57e-01 | 97.5% | 76.0% |
| 4950139 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.70 | 60.0 | 5.99e-01 | 92.6% | 99.2% |
| 5009713 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.70 | 63.0 | 5.72e-01 | 97.5% | 95.0% |
| 6380 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.70 | 62.0 | 5.72e-01 | 95.9% | 92.2% |
| 4283272 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.70 | 64.0 | 5.66e-01 | 99.2% | 89.4% |
| 6408 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.70 | 62.0 | 5.84e-01 | 98.3% | 88.6% |
| 1674783 | 243.1.1.15 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › T4BSS_DotI_IcmL | 0.70 | 63.0 | 6.01e-01 | 98.3% | 96.4% |
| 3727055 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.70 | 62.0 | 5.86e-01 | 98.3% | 94.5% |
| 4016448 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.70 | 59.0 | 5.60e-01 | 92.6% | 96.6% |
| 3731745 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.69 | 62.0 | 5.63e-01 | 97.5% | 83.1% |
| 2834504 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.69 | 61.0 | 5.59e-01 | 95.0% | 92.2% |
| 3958251 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 62.0 | 5.77e-01 | 100.0% | 85.7% |
| 3930653 | 243.3.1.1 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › Cystatin | 0.69 | 49.0 | 5.50e-01 | 94.2% | 97.8% |
| 399927 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.69 | 62.0 | 5.71e-01 | 98.3% | 87.6% |
| 4676601 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.69 | 62.0 | 5.51e-01 | 97.5% | 89.9% |
| 3432106 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.69 | 51.0 | 5.09e-01 | 93.4% | 75.4% |
| 170212 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.69 | 58.0 | 5.90e-01 | 91.7% | 98.3% |
| 3941713 | 243.1.1.6 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › VirB8 | 0.69 | 60.0 | 5.76e-01 | 95.9% | 100.0% |
| 3056323 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.68 | 60.0 | 5.46e-01 | 95.0% | 91.8% |
| 3515333 | 243.3.1.0 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin | 0.68 | 49.0 | 5.60e-01 | 93.4% | 100.0% |
| 3278323 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.68 | 61.0 | 6.01e-01 | 97.5% | 95.4% |
| 4315252 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.68 | 61.0 | 5.74e-01 | 97.5% | 89.7% |
| 4312776 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.68 | 60.0 | 5.50e-01 | 95.0% | 92.2% |
| 3960457 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 62.0 | 5.71e-01 | 100.0% | 89.7% |
| 3427427 | 243.3.1.47 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF7074 | 0.68 | 48.0 | 5.49e-01 | 96.7% | 98.9% |
| 4472109 | 243.1.1.103 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF30257 | 0.68 | 58.0 | 5.85e-01 | 93.4% | 93.3% |
| 3291726 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.68 | 60.0 | 5.61e-01 | 99.2% | 85.7% |
| 4884000 | 243.1.1.1 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Ring_hydroxyl_B | 0.68 | 55.0 | 5.06e-01 | 86.8% | 91.7% |
| 3698353 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 59.0 | 5.87e-01 | 95.0% | 100.0% |
| 4152363 | 243.1.1.115 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29733 | 0.68 | 60.0 | 5.98e-01 | 96.7% | 97.6% |
| 3953277 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.67 | 58.0 | 5.50e-01 | 95.0% | 90.3% |
| 3731226 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.67 | 60.0 | 5.54e-01 | 95.0% | 86.0% |
| 3281675 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.67 | 51.0 | 5.42e-01 | 80.2% | 100.0% |
| 2632043 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.67 | 59.0 | 5.69e-01 | 97.5% | 95.0% |
| 3281242 | 243.1.1.26 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_4 | 0.67 | 58.0 | 5.68e-01 | 95.0% | 96.9% |
| 3230449 | 243.1.1.82 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26529 | 0.66 | 60.0 | 5.52e-01 | 100.0% | 91.6% |
| 3591282 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.65 | 55.0 | 5.61e-01 | 92.6% | 99.2% |
| 3541529 | 883.1.1.15 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP+LBP_BPI_CETP_C | 0.63 | 56.0 | 3.88e-01 | 99.2% | 32.8% |
| 5003871 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.62 | 55.0 | 5.29e-01 | 98.3% | 97.9% |
| 4097328 | 9.3.1.3 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Eryth_link_C | 0.62 | 41.0 | 4.12e-01 | 89.3% | 65.6% |
| 3226411 | 243.1.1.82 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF26529 | 0.61 | 53.0 | 4.95e-01 | 96.7% | 96.0% |
| 3289158 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.60 | 51.0 | 5.31e-01 | 95.0% | 100.0% |
| 861 | 9.3.1.3 ↗ | beta barrels › Lipocalins/Streptavidin › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Quinohemoprotein amine dehydrogenase A chain, domain 3-like › Eryth_link_C | 0.60 | 42.0 | 4.17e-01 | 91.7% | 68.0% |
| 4647627 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.60 | 53.0 | 4.44e-01 | 100.0% | 63.7% |
| 137634 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.59 | 52.0 | 5.11e-01 | 98.3% | 96.9% |
| 3530920 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.59 | 52.0 | 4.39e-01 | 98.3% | 68.3% |
| 3818687 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.57 | 50.0 | 4.72e-01 | 95.0% | 81.4% |
| 3807704 | 11.1.1.0 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like | 0.56 | 51.0 | 4.78e-01 | 98.3% | 89.3% |
| 3620624 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.56 | 50.0 | 4.23e-01 | 100.0% | 63.8% |
| 3399804 | 206.1.1.55 ↗ | a+b complex topology › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase › EcKL | 0.56 | 45.0 | 3.18e-01 | 86.8% | 31.4% |
| 4445572 | 4099.1.1.22 ↗ | a+b two layers › Kinetochore globular domain-like › Kinetochore globular domain-like › Kinetochore globular domain-like › CENP-P | 0.56 | 35.0 | 3.44e-01 | 81.0% | 57.7% |
| 3937238 | 331.3.1.17 ↗ | a+b two layers › TBP-like › Bet v1-like › Bet v1-like › VASt | 0.54 | 41.0 | 3.37e-01 | 90.1% | 44.1% |
| 3653384 | 708.1.1.1 ↗ | beta complex topology › ETN0001 domain-like › ETN0001 domain-like › NAC/WRKY/GCM/WOPR domain › NAM | 0.53 | 41.0 | 3.81e-01 | 82.6% | 69.0% |
| 4559320 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.53 | 45.0 | 3.79e-01 | 98.3% | 55.1% |
| 4025861 | 4051.1.1.1 ↗ | a+b two layers › a+b domain in Capz › a+b domain in Capz › a+b domain in Capz › F_actin_cap_B | 0.52 | 46.0 | 4.10e-01 | 95.0% | 81.2% |
| 3569021 | 883.1.1.1 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like › LBP_BPI_CETP | 0.52 | 47.0 | 4.08e-01 | 99.2% | 67.6% |
D2
high
residues 189-308
Domain cluster:
representative
CATH (45)
| Domain ID | Class ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3ub1D02 | 3.10.450.540 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.81 | 70.0 | 7.26e-01 | 95.8% | 96.5% |
| 2rgqB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.76 | 62.0 | 6.00e-01 | 85.8% | 88.7% |
| 4kz1A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.76 | 62.0 | 5.92e-01 | 85.0% | 96.3% |
| 3gwrB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 61.0 | 6.02e-01 | 85.0% | 93.7% |
| 3b8lA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.75 | 61.0 | 5.79e-01 | 85.8% | 87.9% |
| 4gb5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.74 | 61.0 | 5.62e-01 | 85.8% | 88.5% |
| 1of5B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 61.0 | 5.95e-01 | 86.7% | 94.5% |
| 2f86B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 62.0 | 6.04e-01 | 89.2% | 96.9% |
| 3hx8A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 59.0 | 5.81e-01 | 85.0% | 93.0% |
| 7c5wA01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 60.0 | 5.58e-01 | 87.5% | 100.0% |
| 3h51A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 60.0 | 5.70e-01 | 88.3% | 89.4% |
| 1ar0A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.73 | 60.0 | 5.91e-01 | 86.7% | 91.2% |
| 2cc3A00 | 3.10.450.230 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › VirB8 protein | 0.73 | 61.0 | 5.67e-01 | 87.5% | 93.1% |
| 3f7sA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 58.0 | 5.51e-01 | 85.8% | 84.5% |
| 3k7cA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.72 | 57.0 | 6.02e-01 | 83.3% | 100.0% |
| 3cnxA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 57.0 | 5.49e-01 | 85.8% | 93.5% |
| 1jkgA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.71 | 59.0 | 5.61e-01 | 88.3% | 89.2% |
| 2qiyA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 57.0 | 5.54e-01 | 87.5% | 95.5% |
| 3nv0B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 58.0 | 5.57e-01 | 88.3% | 89.0% |
| 2jq5A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.70 | 59.0 | 5.76e-01 | 90.0% | 96.1% |
| 3ecfA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.69 | 57.0 | 5.55e-01 | 85.8% | 82.0% |
| 3q90B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.68 | 56.0 | 5.46e-01 | 87.5% | 87.7% |
| 5aigA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 54.0 | 5.37e-01 | 86.7% | 89.5% |
| 3kztA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.66 | 55.0 | 5.37e-01 | 89.2% | 93.2% |
| 2ckfB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 54.0 | 4.78e-01 | 88.3% | 86.5% |
| 2imjD01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 54.0 | 5.08e-01 | 87.5% | 78.9% |
| 2bmoB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.65 | 57.0 | 4.84e-01 | 95.0% | 88.1% |
| 1aqbA00 | 2.40.128.20 | Mainly Beta › Beta Barrel › Lipocalin › Calycin beta-barrel core domain | 0.65 | 39.0 | 3.45e-01 | 89.2% | 41.7% |
| 1uliB00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.63 | 54.0 | 4.75e-01 | 92.5% | 90.4% |
| 3er7B00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.62 | 50.0 | 5.01e-01 | 85.8% | 94.3% |
| 3d2lA02 | 2.20.25.110 | Mainly Beta › Single Sheet › N-terminal domain of TfIIb › S-adenosyl-L-methionine-dependent methyltransferases | 0.62 | 29.0 | 3.89e-01 | 78.3% | 84.1% |
| 3ff0A01 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 50.0 | 4.74e-01 | 86.7% | 85.1% |
| 2a15A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 49.0 | 4.78e-01 | 85.8% | 89.5% |
| 5tgnA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 49.0 | 5.12e-01 | 85.8% | 94.5% |
| 3ebtA00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.61 | 49.0 | 4.80e-01 | 85.8% | 88.5% |
| 3bxoA02 | 2.20.130.10 | Mainly Beta › Single Sheet › S-adenosyl-L-methionine-dependent methyltransferases › CAC2371-like domains | 0.58 | 28.0 | 3.80e-01 | 79.2% | 93.2% |
| 3f14A00 | 3.10.450.50 | Alpha Beta › Roll › Nuclear Transport Factor 2; Chain: A, › | 0.57 | 45.0 | 4.70e-01 | 85.8% | 97.3% |
| 1usuB00 | 3.15.10.20 | Alpha Beta › Super Roll › Bactericidal permeability-increasing protein; domain 1 › Activator of Hsp90 ATPase Aha1, N-terminal domain | 0.57 | 44.0 | 4.29e-01 | 80.8% | 95.5% |
| 1wznA02 | 2.20.25.110 | Mainly Beta › Single Sheet › N-terminal domain of TfIIb › S-adenosyl-L-methionine-dependent methyltransferases | 0.56 | 27.0 | 3.64e-01 | 90.0% | 94.6% |
| 4eg9A00 | 2.50.20.40 | Mainly Beta › Clam › outer membrane lipoprotein receptor (LolB), chain A › | 0.54 | 43.0 | 3.48e-01 | 85.8% | 89.2% |
| 1h2iA01 | 3.30.390.80 | Alpha Beta › 2-Layer Sandwich › Enolase-like; domain 1 › DNA repair protein Rad52/59/22 | 0.53 | 37.0 | 3.46e-01 | 70.0% | 72.3% |
| 3d30A02 | 2.60.40.760 | Mainly Beta › Sandwich › Immunoglobulin-like › Expansin, cellulose-binding-like domain | 0.53 | 35.0 | 3.92e-01 | 83.3% | 85.1% |
| 3uc2A00 | 2.60.40.3340 | Mainly Beta › Sandwich › Immunoglobulin-like › Domain of unknown function DUF4426 | 0.53 | 36.0 | 3.60e-01 | 85.0% | 66.9% |
| 4rljA00 | 3.10.129.10 | Alpha Beta › Roll › Thiol Ester Dehydrase; Chain A › Hotdog Thioesterase | 0.53 | 37.0 | 3.48e-01 | 85.8% | 58.3% |
| 2okmA00 | 2.60.40.740 | Mainly Beta › Sandwich › Immunoglobulin-like › | 0.50 | 35.0 | 3.33e-01 | 73.3% | 87.7% |
ECOD (74)
| UID | F-ID | Classification | TM-score | Bits | E-value | Q cov | T cov |
|---|---|---|---|---|---|---|---|
| 3277625 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.89 | 85.0 | 8.56e-01 | 100.0% | 100.0% |
| 4977542 | 243.1.1.22 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › Lumazine_bd_2 | 0.78 | 63.0 | 6.15e-01 | 85.0% | 97.7% |
| 3959230 | 243.1.1.77 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF29518 | 0.77 | 64.0 | 6.04e-01 | 86.7% | 86.4% |
| 3284019 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.77 | 63.0 | 6.08e-01 | 86.7% | 91.1% |
| 3948878 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.75 | 61.0 | 6.04e-01 | 85.8% | 97.6% |
| 2724315 | 243.1.1.81 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › PF27546 | 0.74 | 60.0 | 5.36e-01 | 85.8% | 90.2% |
| 3284644 | 243.1.1.71 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF8176 | 0.73 | 61.0 | 6.04e-01 | 87.5% | 88.8% |
| 4464528 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 58.0 | 6.08e-01 | 83.3% | 100.0% |
| 3733425 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.73 | 61.0 | 5.70e-01 | 88.3% | 88.3% |
| 3471294 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.73 | 61.0 | 5.93e-01 | 88.3% | 93.0% |
| 2523962 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.72 | 60.0 | 5.94e-01 | 88.3% | 89.8% |
| 3710606 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.72 | 61.0 | 5.86e-01 | 89.2% | 89.6% |
| 3287191 | 243.1.1.71 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF8176 | 0.72 | 61.0 | 6.10e-01 | 89.2% | 94.2% |
| 3798282 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 59.0 | 5.89e-01 | 87.5% | 95.2% |
| 3223708 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 60.0 | 6.05e-01 | 88.3% | 98.3% |
| 3589048 | 243.1.1.7 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › MecA_N | 0.72 | 59.0 | 5.60e-01 | 86.7% | 82.1% |
| 4135737 | 243.1.1.66 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › TcaA_5th | 0.72 | 57.0 | 5.82e-01 | 84.2% | 94.8% |
| 3474450 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.72 | 59.0 | 5.83e-01 | 86.7% | 90.4% |
| 3244404 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.72 | 59.0 | 5.93e-01 | 88.3% | 96.7% |
| 4460572 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.72 | 58.0 | 5.69e-01 | 85.8% | 82.3% |
| 3446904 | 243.3.1.12 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › SQAPI | 0.72 | 49.0 | 5.59e-01 | 90.8% | 94.4% |
| 3713083 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.71 | 59.0 | 5.78e-01 | 88.3% | 93.8% |
| 3889571 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.71 | 59.0 | 5.91e-01 | 87.5% | 91.9% |
| 3785652 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.71 | 59.0 | 5.35e-01 | 88.3% | 90.6% |
| 6392 | 243.1.1.25 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_3 | 0.71 | 57.0 | 5.49e-01 | 85.8% | 93.5% |
| 3678591 | 243.3.1.12 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › SQAPI | 0.71 | 46.0 | 5.25e-01 | 86.7% | 87.8% |
| 3681671 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.71 | 59.0 | 5.43e-01 | 87.5% | 91.3% |
| 3741071 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.71 | 58.0 | 5.51e-01 | 86.7% | 85.0% |
| 3285905 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 58.0 | 5.64e-01 | 86.7% | 90.8% |
| 3600301 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 58.0 | 5.81e-01 | 88.3% | 97.6% |
| 3830041 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.71 | 58.0 | 5.71e-01 | 87.5% | 88.5% |
| 4011330 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.71 | 58.0 | 5.56e-01 | 86.7% | 85.9% |
| 3242736 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.70 | 58.0 | 5.51e-01 | 87.5% | 86.4% |
| 3216464 | 243.1.1.28 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF4440 | 0.70 | 58.0 | 5.77e-01 | 88.3% | 97.6% |
| 3278526 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.70 | 57.0 | 5.51e-01 | 86.7% | 91.1% |
| 3217508 | 243.1.1.97 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF5382_N | 0.70 | 57.0 | 5.61e-01 | 85.8% | 97.6% |
| 3277627 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.70 | 59.0 | 6.03e-01 | 89.2% | 93.0% |
| 3247589 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.70 | 59.0 | 5.70e-01 | 89.2% | 89.5% |
| 3217155 | 243.1.1.97 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF5382_N | 0.70 | 56.0 | 5.24e-01 | 85.8% | 81.3% |
| 143958 | 243.1.1.2 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2 | 0.70 | 58.0 | 5.57e-01 | 88.3% | 89.0% |
| 3735183 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.70 | 56.0 | 5.57e-01 | 85.0% | 93.6% |
| 3516488 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 58.0 | 5.63e-01 | 88.3% | 92.3% |
| 3732444 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 58.0 | 5.42e-01 | 90.0% | 91.0% |
| 3283292 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.69 | 55.0 | 5.40e-01 | 85.0% | 87.7% |
| 3479831 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.69 | 55.0 | 4.98e-01 | 86.7% | 77.0% |
| 3236685 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.68 | 56.0 | 5.72e-01 | 86.7% | 99.1% |
| 3950757 | 243.1.1.7 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › MecA_N | 0.68 | 55.0 | 5.66e-01 | 88.3% | 89.6% |
| 3219090 | 243.1.1.47 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF5390 | 0.68 | 55.0 | 5.49e-01 | 85.8% | 96.7% |
| 3330850 | 243.3.1.12 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › SQAPI | 0.68 | 51.0 | 5.55e-01 | 90.8% | 94.0% |
| 4978484 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.67 | 55.0 | 5.34e-01 | 85.8% | 83.1% |
| 5048351 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.67 | 54.0 | 5.09e-01 | 85.8% | 75.9% |
| 3729692 | 243.1.1.0 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like | 0.66 | 55.0 | 5.08e-01 | 90.0% | 93.5% |
| 3419997 | 243.3.1.19 ↗ | a+b two layers › Cystatin-like › Cystatin/monellin › Cystatin/monellin › DUF3615 | 0.66 | 50.0 | 5.21e-01 | 94.2% | 85.3% |
| 1562270 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.66 | 54.0 | 5.37e-01 | 86.7% | 89.5% |
| 3280323 | 243.1.1.7 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › MecA_N | 0.66 | 52.0 | 5.52e-01 | 84.2% | 96.2% |
| 2785694 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.66 | 53.0 | 5.23e-01 | 86.7% | 86.7% |
| 3268473 | 243.1.1.87 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › NTF2_SigF | 0.65 | 50.0 | 5.01e-01 | 81.7% | 88.8% |
| 3418771 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.65 | 52.0 | 5.10e-01 | 85.0% | 87.7% |
| 3282929 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.65 | 52.0 | 5.29e-01 | 85.0% | 90.8% |
| 3829053 | 243.1.1.49 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF2358 | 0.64 | 52.0 | 4.92e-01 | 85.0% | 81.4% |
| 3281821 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.64 | 51.0 | 4.99e-01 | 83.3% | 92.3% |
| 3217156 | 243.1.1.46 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › DUF5382 | 0.64 | 51.0 | 4.88e-01 | 85.8% | 93.6% |
| 5068089 | 283.1.1.0 ↗ | a+b duplicates or obligate multimers › Creatinase/aminopeptidase-like › Creatinase/aminopeptidase › Creatinase/aminopeptidase | 0.63 | 38.0 | 3.89e-01 | 78.3% | 60.9% |
| 3957839 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.63 | 53.0 | 5.15e-01 | 90.0% | 91.5% |
| 6400 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.62 | 49.0 | 5.03e-01 | 85.8% | 98.3% |
| 2388320 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.61 | 49.0 | 4.77e-01 | 85.8% | 88.6% |
| 3225768 | 883.1.1.0 ↗ | a+b complex topology › Aha1/BPI domain-like › Aha1/BPI domain-like › Aha1/BPI domain-like | 0.60 | 45.0 | 4.02e-01 | 90.8% | 55.3% |
| 4927976 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.58 | 47.0 | 4.66e-01 | 86.7% | 96.0% |
| 169507 | 243.1.1.18 ↗ | a+b two layers › Cystatin-like › NTF2-like › NTF2-like › SnoaL_2 | 0.57 | 45.0 | 4.69e-01 | 85.8% | 97.3% |
| 5029269 | 11.1.1.0 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like | 0.56 | 41.0 | 4.24e-01 | 76.7% | 81.7% |
| 3185089 | 9.1.1.37 ↗ | beta barrels › Lipocalins/Streptavidin › Lipocalins › Lipocalins › DUF6314 | 0.54 | 43.0 | 3.69e-01 | 90.8% | 53.8% |
| 3406042 | 206.1.1.55 ↗ | a+b complex topology › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase/SAICAR synthase/ATP-grasp › Protein kinase › EcKL | 0.54 | 46.0 | 3.22e-01 | 92.5% | 35.6% |
| 4158607 | 71.1.1.5 ↗ | beta meanders › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › Lipoprotein localization factors LolAB › DUF576 | 0.52 | 44.0 | 3.61e-01 | 93.3% | 90.6% |
| 5016736 | 11.1.1.0 ↗ | beta sandwiches › Immunoglobulin-like beta-sandwich › Immunoglobulin-related › Immunoglobulin/Fibronectin type III/E set domains/PapD-like | 0.51 | 35.0 | 3.75e-01 | 75.0% | 81.9% |